Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
KU Leuven
With
Chiesi Farmaceutici S.p.A.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
clinical diagnosis COPD according to last updated GOLD guidelines (post- bronchodilator FEV/FVC below 0,70, FEV1 \<80% predicted)
ex-smokers (ie 1 year from the last cigarette) with at least 10 pack years.
GOLD stage II and III (FEV1 \> 30% predicted)
by preference naïve to inhaled corticosteroids; in those taking inhaled corticosteroids this medication will be stopped 1 month prior to enrollment in the study
Patients must have proven small airways dysfunction on routine spirometry as reflected by a drop in FEF25-75 and FEF75 of at least 50%. Moreover, patients must have proven small airways dysfunction on MBW as reflected by Sacin \>0,120 that is considered abnormal.
You may not be if
Current smoking
Active COPD exacerbation
gold stage I and IV
Clareo Health | Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function
